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The mechanisms underlying the destruction of bone tissue in osteomyelitis are only
now being elucidated. While some of the tissue damage associated with osteomyelitis
likely results from the direct actions of bacteria and infiltrating leukocytes, perhaps
exacerbated by bacterial manipulation of leukocyte survival pathways, infection-induced
bone loss predominantly results from an uncoupling of the activities of osteoblasts and
osteoclasts. Bacteria or their products can directly increase osteoclast formation and
activity, and the inflammatory milieu at sites of infection can further promote bone
resorption. In addition, osteoclast activity is critically regulated by osteoblasts that can
respond to bacterial pathogens and foster both inflammation and osteoclastogenesis.
Importantly, bone loss during osteomyelitis is also brought about by a decline in new bone
deposition due to decreased bone matrix synthesis and by increased rates of osteoblast
apoptosis. Extracellular bacterial components may be sufficient to reduce osteoblast
viability, but the causative agents of osteomyelitis are also capable of inducing continuous
apoptosis of these cells by activating intrinsic and extrinsic cell death pathways to further
uncouple bone formation and resorption. Interestingly, bacterial internalization appears
to be required for maximal osteoblast apoptosis, and cytosolic inflammasome activation
may act in concert with autocrine/paracrine death receptor-ligand signaling to induce cell
death. The manipulation of apoptotic pathways in infected bone cells could be an attractive
new means to limit inflammatory damage in osteomyelitis. However, the mechanism
that is the most important in bacterium-induced bone loss has not yet been identified.
Furthermore, it remains to be determined whether the host would be best served by
preventing osteoblast cell death or by promoting apoptosis in infected cells.
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INTRODUCTION
Osteomyelitis is a severe infection of bone tissue that is associated
with significant morbidity and typically leads to bone resorp-
tion, dysfunction, and progressive inflammatory destruction (Sax
and Lew, 1999). Such infections are characterized in rodent
models by the rapid production of inflammatory mediators, fol-
lowed by infiltration of leukocytes at 3–7 days after infection,
and subsequent bone resorption and adjacent areas of new bone
deposition at 14–28 days (Yoshii et al., 2002). Staphylococcus
aureus and Salmonella spp. are the most common causative agents
of osteomyelitis. S. aureus accounts for approximately 80% of
all osteomyelitis cases (Lew and Waldvogel, 2004; Labbé et al.,
2010) while Salmonella species represent one of the most serious
pathogens of bone in sickle cell patients and immunosuppressed
patients (Anand and Glatt, 1994; Workman et al., 1996; Koehler
et al., 1998; Overturf, 1999). S. aureus has a propensity to colo-
nize broken skin and so a history of trauma or skin infection is a
significant risk factor for bone and joint infections caused by this
organism (Barton et al., 1987; Dubey et al., 1988). The majority
of bone infections in children are caused by hematogenous spread
of bacteria from distant infection foci through the bloodstream,
while most cases in adults result from external sources such as
post-traumatic wounds and post-operative infections (Mousa,
2003; De Boeck, 2005). Indeed, implant-related infection is such
a feared complication in orthopedic surgery that perioperative
administration of antibiotics is routinely used to reduce this risk
(Davis, 2005). However, despite prophylaxis and improvements
in the diagnosis of osteomyelitis, the incidence and severity of
these bone infections appear to be increasing (Jensen et al., 1997;
Arnold et al., 2006).
While osteomyelitis is associated with progressive inflamma-
tory tissue destruction, such infections also result in marked bone
resorption at sites of infection and proximal abnormal bone for-
mation. The continual process of bone remodeling requires the
coordinated regulation of the genesis and activity of osteoblasts
and osteoclast lineages. Osteoclasts drive the resorption of bone
by acidification and release of lysosomal enzymes (Teitelbaum
et al., 1997). In contrast, osteoblasts produce components of
bone, principally type I collagen, and catalyze the calcification
process. As such, any interference with these integrated cell
types can result in abnormal bone remodeling. Bacteria such
as S. aureus and their products can be potent stimulators of
resorptive bone loss (Nair et al., 1995, 1996). While bacteria can
directly damage bone by producing acids and proteases, they can
also stimulate osteoclastogenesis. For example, the site of infec-
tion in animal models of S. aureus osteomyelitis contains high
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numbers of macrophages and osteoclasts (Wiggers et al., 2011),
and S. aureus surface-associated proteins can stimulate osteoclast
formation and activity (Meghji et al., 1998; Lau et al., 2006).
Similarly, systemically administered lipopolysaccharide (LPS) or
local application of LPS derived from Aggregatibacter actino-
mycetemcomitans can reduce bone volume (Ochi et al., 2010;
Madeira et al., 2013) and macrophages and osteoclast-like cells
respond to this Gram-negative bacterial product by releasing
cytokines and nitric oxide (NO) (Wiggers et al., 2011). However,
it is unclear whether such effects are due to a direct action
on osteoclasts and/or their progenitors, or are secondary to the
production of other mediators, such as inflammatory cytokines,
which modulate osteoclast formation and activity (Meghji et al.,
1998).
Importantly, it is becoming increasingly apparent that, in addi-
tion to increased osteolysis and direct inflammatory degradation
of bone matrix, tissue damage during osteomyelitis progression
is associated with significant bone cell death. Again, cultured
macrophages and osteoclasts can respond to LPS and S. aureus by
releasing factors such as NO that can promote cell death (Wiggers
et al., 2011). Importantly, osteonecrosis of the jaw is character-
ized by high-grade inflammation and large lesions coupled with
osteocyte apoptosis (Lesclous et al., 2009). The death of this cell
type is especially important given that this bonematrix embedded
cell type regulates the bone remodeling activities of bone surface
osteoclasts and osteoblasts via the lacuna-canaliculi network (as
discussed in Matsuo, 2009). Furthermore, apoptotic cells accom-
pany trabecular osteolysis in porcine models of osteomyelitis, in a
similar manner to that typically observed in osteomyelitic lesions
in following hematological S. aureus spread (Jensen et al., 2010).
In the present review, we provide an overview of the mechanisms
that can directly or indirectly induce bone cell death following
infection and we discuss the possible significance of modulated
programmed cell death in the progression of osteomyelitis.
ROLE OF RESIDENT BONE CELLS IN INFLAMMATORY BONE
LOSS ASSOCIATED WITH OSTEOMYELITIS
Current treatment for osteomyelitis involves expensive and pro-
longed (even lifelong) parenteral antibiotic treatment, surgically
debridement of necrotic bone, and often amputation. While these
strategies are effective in reducing or eliminating the ability to
isolate culturable bacteria from affected tissue, osteomyelitis is
often refractory with a recent retrospective study revealing that
a bacteriological cure was not achieved in up to 17% of cases
(Priest and Peacock, 2005). Possible explanations for this persis-
tence include the increasing incidence of antibiotic resistance in
S. aureus and Salmonella spp. (Workman et al., 1996; Heseltine,
2000), with the appearance of isolates that are even resistant
(Boneca and Chiosis, 2003) or less susceptible (Tenover et al.,
2001) to vancomycin, and the formation of staphylococcal bac-
terial biofilms that may render these organisms less susceptible
to host immune attack (as reviewed in Brady et al., 2008; Hanke
and Kielian, 2012). However, recent in vitro studies have demon-
strated that neutrophils can recognize biofilms and respond by
phagocytosis and release of lactoferrin, elastase, and DNA sug-
gesting that staphylococcal biofilms are not inherently resistant
to neutrophil-mediated destruction, although it remains to be
determined how effectively these cells attack biofilms in vivo
(Meyle et al., 2010). Furthermore, these explanations fail to fully
account for the observation that up to 50% of “cured” osteomyeli-
tis cases display infection-related sequelae. Indeed, patients can
have recurrent attacks of osteomyelitis following the completion
of treatment regimens even when causative organisms can no
longer be isolated from infection sites (Priest and Peacock, 2005).
An alternative explanation for these phenomena may lie in
the ability of the causative agents of osteomyelitis to invade and
reside within resident bone cells. An intracellular lifestyle pro-
vides advantages to a variety of microbes that include access to
host cell metabolites (as discussed in Ray et al., 2009; Wright
and Nair, 2010; Friedrich et al., 2012). Importantly, internaliza-
tion also provides a means of protection against neutrophil and
antibody-mediated immune responses, and mitigates therapeu-
tic interventions by limiting exposure to antibiotics. Salmonella
species are intracellular bacterial pathogens and this organism is
recognized to invade epithelial cells (Rosenshine et al., 1994; Jones
and Falkow, 1996; Ohl and Miller, 2001). Importantly, we have
demonstrated that this bacterium can invade primary osteoblasts
(Bost et al., 2000). In contrast, staphylococci have tradition-
ally been regarded as non-invasive pathogens that damage host
bone cells after adhering to the extracellular matrix (Nair et al.,
1996). However, it is becoming increasingly apparent that these
organisms can be internalized by cultured osteoblasts and can
persist intracellularly (Hudson et al., 1995; Ellington et al., 1999,
2003, 2006; Jevon et al., 1999; Ahmed et al., 2001). Osteoblasts
appear to be active in this invasion process as evidenced by the
requirement that these cells, but not bacteria, be alive for inter-
nalization to occur (Hudson et al., 1995; Ellington et al., 1999).
Furthermore, reorganization of the osteoblast cytoskeleton and
receptor-mediated endocytosis are utilized in the internalization
process (Ellington et al., 1999; Jevon et al., 1999). It is important
to note that bacteria released following lysis or trypsinization of
S. aureus-containing human osteoblasts are viable and are capable
of invading other osteoblasts (Ellington et al., 2003). In addition,
significant time-dependent changes in the structure of S. aureus
can occur after as little as 12 h exposure to an intracellular envi-
ronment that render the organisms less sensitive to antibiotics
capable of penetrating eukaryotic cells (Ellington et al., 2006).
Interestingly, the ability of bacteria to invade osteoblasts may also
direct the ability of this organism to form biofilms and it has
been suggested that invasion promotes a biofilm-like surface on
S. aureus that correlates with antibiotic resistance (Brady et al.,
2008). As such, these host evasion mechanisms may be intimately
related (Brady et al., 2008). Such findings may explain why antibi-
otic treatment can reduce the number of viable bacteria in animal
models of staphylococcal osteomyelitis but does not reliably ster-
ilize infected bone (Monzón et al., 2001). Bacteria sequestered
inside the osteoblast may therefore provide a reservoir of bacte-
ria and contribute to recurrent chronic osteomyelitis that often
occurs despite the presence of antibiotics and a seemingly ade-
quate humoral response (Lew and Waldvogel, 2004).
In addition to the synthesis of new bone matrix, osteoblasts
produce soluble factors that regulate the formation and activity
of osteoclasts. For example, osteoblasts are an important source of
receptor activator of NF-kB ligand (RANKL) and osteoprotegerin
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(OPG), critical regulators of osteoclast development and function
(Wada et al., 2006). RANKL interacts with its receptor RANK on
osteoclast progenitor cells and plays a central role in promoting
osteoclast formation and activity (Hsu et al., 1999; Kong et al.,
1999a,b; Kim et al., 2000; Li et al., 2000; Wada et al., 2006). In
contrast, OPG functions as a decoy receptor for RANKL and lim-
its osteoclastogenesis (Wada et al., 2006). Interestingly, causative
agents of periodontal infections such as Porphyromonas gingivalis
have been found to induce the RANKL expression in osteoblasts
(Okahashi et al., 2004) and elevated levels of this molecule have
been found in osteomyelitis-associated bone lesions (Montonen
et al., 2006). While such RANKL production may be attributable
to the activity of resident bone cells, it should be noted that acti-
vated T-lymphocytes also produce this cytokine (Anderson et al.,
1997; Horwood et al., 1999; Hsu et al., 1999). RANKL production
by osteoblasts and T-cells can be stimulated by the inflammatory
cytokines interleukin (IL)-1β and tumor necrosis factor-α TNF-α
(Walsh and Choi, 2003) that are detectable in infected bone tis-
sues of osteomyelitis patients (O’Keefe et al., 1997). In addition,
both of these inflammatory mediators have been demonstrated to
concomitantly depress OPG expression in osteoblasts and we have
shown that S. aureus challenge similarly inhibits osteoblast pro-
duction of this RANKL decoy receptor (Young et al., 2011). This
then provides another mechanism that can favor bone resorp-
tion at sites of infection. Finally, Choi et al. (2005) have shown
that cyclooxygenase-2 (COX2) inhibitors can inhibit P. gingi-
valis-induced RANKL expression by osteoblasts and restore OPG
levels. This observation is in agreement with our own recent stud-
ies demonstrating that S. aureus elevates RANKL production by
osteoblasts and this effect is similarly abolished by a specific COX2
inhibitor (Somayaji et al., 2008). These findings suggest that
osteoblasts produce PGE2 that acts in a paracrine or autocrine
manner to induce RANKL release and limit OPG production,
creating a microenvironment that favors bone resorption (Choi
et al., 2005). Together, these data suggest that bacterially chal-
lenged osteoblasts can promote the formation and activity of
osteoclasts leading to a net loss of bone at sites of infection (as
summarized in Figure 1).
But the activities of osteoblasts may not be limited to the syn-
thesis of bonematrix components and the regulation of osteoclast
activity. There is increasing evidence that osteoblasts may directly
contribute to inflammation in infected bone tissue. Studies from
our group and others have demonstrated that isolated osteoblasts
utilize members of the toll-like receptor (TLR) and nucleotide-
binding oligomerization domain-containing (NOD)-like recep-
tor (NLR) families of innate immune receptors to detect the
presence of microbial products (Gasper et al., 2002; Madrazo
et al., 2003; Marriott et al., 2005; Chauhan and Marriott, 2010)
(Figure 1). The activation of these sensors precipitates transcrip-
tion factor activation and leads to the release of inflammatory
cytokines and the expression of cell surface antigen presenting
and co-stimulatory molecules (Barton and Medzhitov, 2003).
Consistent with this observation, our in vitro studies show that
S. aureus is a potent stimulus for the production of soluble
and cell surface molecules by isolated osteoblasts that could
play key roles in the initiation and/or progression of inflamma-
tory immune responses (Marriott, 2004). Such molecules include
FIGURE 1 | Bacterial infection leads to inflammatory bone loss
resulting from increased formation and/or activity of bone resorbing
osteoclasts, and a decrease in the number of bone forming
osteoblasts. Osteoblasts (OB) can recognize bacteria and their
components such as LPS, flagellin, or unmethylated CpG DNA motifs (CpG)
via cell surface pattern recognition receptors including TLRs 4, 5, and 9, and
the cytosolic sensors NOD1, NOD2, and NLRP3. These microbial sensors
can directly or indirectly (via PGE2 autocrine/paracrine signaling) induce the
rapid release of chemokines such as CCL2, CCL3, and CXCL10 to recruit
leukocytes including T-lymphocytes (T) to the site of infection. Bacterially
stimulated osteoblasts show elevated levels of these bacterial sensors and
can also express cell surface molecules including MHC class II and CD40
that can elicit antigen-specific activation of infiltrating T-cells. Bacteria and
their components can directly induce the formation and activity of
osteoclasts (OC) or indirectly activate these cells via the autocrine/paracrine
actions of released TNF-a. In addition, activated T-cells and osteoblasts
produce an array of molecules including RANKL, IL-6, IFN-γ and colony
stimulating factors (M-CSF, G-CSF, GM-CSF) that can promote
osteoclastogenesis and bone resorption, and activation of osteoblasts
decreases the production of the RANKL decoy receptor OPG. Finally,
bacteria can induce the apoptotic death of osteoblasts either directly via the
NLRP3 inflammasome, or indirectly via the autocrine/paracrine actions of
released TRAIL interacting with death receptors (DR) expressed on the
surface of challenged cells. Since OPG also functions as a decoy receptor
for TRAIL, the decreased production of this molecule by infected
osteoblasts could exacerbate TRAIL-induced apoptosis leading to
decreased numbers of this bone forming population and greater bone loss
at sites of infection.
CXCL10 (Gasper et al., 2002) and CCL2 (Bost et al., 2001) that are
potent chemoattractants for T-cells and macrophages, leukocytes
frequently observed in bone tissue following infection (Stashenko
et al., 1992; Bremell et al., 1994), and IL-6 (Bost et al., 1999)
an often inflammatory cytokine that can directly or indirectly
modulate the activity of bone-resorptive osteoclasts (Lowik et al.,
1989; Ishimi et al., 1990; de la Mata et al., 1995; Greenfield et al.,
1995; Hofbauer and Heufelder, 1996). Furthermore, our labo-
ratory has demonstrated that primary osteoblasts can produce
growth factors such as granulocyte macrophage colony stimu-
lating factor (GM-CSF), macrophage colony stimulating factor
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(M-CSF) and granulocyte colony stimulating factor (G-CSF)
following S. aureus exposure (Bost et al., 2000) that could increase
osteoclastogenesis and promote bone resorption (Lorenzo et al.,
1987; Kodama et al., 1991; Takahashi et al., 1991; Liggett et al.,
1993; Povolny and Lee, 1993), and augment immune responses
to this bacterial pathogen (Frenck et al., 1990; Freund and Kleine,
1992; Dale, 1995). As such, the production of these mediators by
bacterially challenged osteoblasts may significantly contribute to
involucrum and sequestrum formation during osteomyelitis, and
exacerbate damaging inflammation.
MODULATION OF LEUKOCYTE APOPTOSIS IN
OSTEOMYELITIS
The interaction between Salmonella species and host cell types
often results in the death of mammalian cells but these bacteria
appear to do so by host cell-type specificmechanisms (as reviewed
in Fink and Cookson, 2007) and the mechanisms underlying
host cell death by such Gram-positive bacterial pathogens have
been extensively reviewed elsewhere (Ulett and Adderson, 2006).
While Salmonella induces apoptosis in epithelial cells, invasion of
macrophages rapidly triggers caspase-1-dependent programmed
cell death, or pyroptosis, in a salmonella pathogenicity island-1
type III secretion system and flagella dependent manner (Fink
and Cookson, 2007). Since caspase-1-deficient mice are more
susceptible to salmonellosis, such pyroptotic death has generally
been considered to be a protective response to infection (Fink
and Cookson, 2007). In contrast, Brucella abortus, an intracellu-
lar zoonotic pathogen that causes osteomyelitis in humans, elicits
host macrophage apoptosis following invasion (Cha et al., 2013).
However, apoptosis only occurs after a period of bacterial repli-
cation and so such cell death appears to favor the pathogen by
eliminating immune cells. Furthermore, it should be noted that
some Gram-positive pathogens of bone including streptococci
also show a capacity to escape in a viable form frommacrophages
in an NO-dependent manner (Ulett and Adderson, 2005).
While several causative agents of osteomyelitis can induce
programmed cell death of infiltrating macrophages, delayed
neutrophil apoptosis is a characteristic feature of human
osteomyelitis arising from either Gram-negative or Gram-positive
organisms (as discussed in Ocaña et al., 2008). Neutrophils from
osteomyelitis patients exhibit less spontaneous apoptosis than
that seen in cells from healthy donors (Asensi et al., 2004).
Interestingly, the serum of osteomyelitis patients has been found
to significantly reduce apoptosis rates over a 12 h time period
in isolated neutrophils (Asensi et al., 2004). This effect has been
attributed to the elevated IL-6 levels seen in patient’s sera as
these anti-apoptotic effects could be reversed with IL-6 neu-
tralizing antibodies or mimicked with exogenous IL-6 (Asensi
et al., 2004). Such cytokine-induced neutrophil apoptosis inhibi-
tion has been demonstrated following infection with the Gram-
positive organism, S. aureus, or the Gram-negative bacterium,
Escherichia coli, and has also been observed following challenge
with lipoteichoic acid (LTA) or LPS, bacterial ligands for TLR2
and TLR4 pattern recognition receptors, respectively (Ocaña
et al., 2008). This auto-induced reduction in neutrophil apoptosis
correlates with an altered ratio of pro-apoptotic B-cell lymphoma
(Bcl)2–associated X protein (Bax) to anti-apoptotic Bcl-extra
large (Bcl-xL) expression in these cells, and this is notable since
the loss-of-function Bax promoter polymorphism A allele has
been found to be more frequent in osteomyelitis patients (Ocaña
et al., 2008). The neutrophils in such patients express less Bax and,
accordingly, lower rates of apoptosis. Similarly, polymorphisms
in the gene encoding TLR4, but not TLR2, have been identified
as risk factors for chronic Gram-negative bacterial osteomyeli-
tis (Montes et al., 2006). Neutrophils isolated from osteomyelitis
patients with TLR4 polymorphisms show less LPS-induced acti-
vation of the key pro-inflammatory transcription factor NF-kB,
reduced IL-6 production, and a lower induced reduction in apop-
tosis (Montes et al., 2006). It is conceivable that inflammatory
cytokine-induced lengthening of neutrophil lifespan represents
an attempt by the host to augment bacterial killing at the site of
infection. However, limiting leukocyte apoptosis in this manner
may ultimately be detrimental to the host due to the exacerbation
of inflammatory damage (Ocaña et al., 2007).
MODULATION OF OSTEOCLAST FORMATION AND SURVIVAL
IN OSTEOMYELITIS
While bacteria or their products can directly destroy bone tis-
sue, they can also indirectly elicit bone loss by increasing the
formation and function of bone-resorbing osteoclasts (Chung
et al., 2006; Maruyama et al., 2006). Indeed, osteoclast responses
in S. aureus-infected tissue differ markedly from those seen in
sterile bone trauma in that these cells behave as acute inflam-
matory responders with substantial activity at the margins of
the infected site and adjacent uninjured tissue (Pesanti and
Lorenzo, 1998). Osteoclastogenesis and osteoclast activity can be
up-regulated by soluble mediators produced by infiltrating leuko-
cytes such as macrophages and neutrophils. For example, the
capsular-like polysaccharide antigen of A. actinomycetemcomi-
tans, an organism implicated in juvenile periodontitis, stimulates
the production of IL-1α that, in turn, promotes osteoclast forma-
tion and bone resorption (discussed in Yamamoto et al., 1999).
Similarly, surface-associated material extracted from S. aureus has
been shown to stimulate osteoclastogenesis and pit formation on
dentine slices in a TNF-α and IL-6 dependent manner (Meghji
et al., 1998). Such induction by cytokines generally considered
to be inflammatory could, in part, explain the large numbers of
osteoclasts that are typically associated with infarcted bone in
osteomyelitis.
However, the formation and bone resorbing functions of
osteoclasts are regulated in large part by osteoblasts and a sub-
stantial body of evidence has accumulated to show that bacterially
challenged osteoblasts produce an array of soluble mediators
that can promote osteoclastogenesis and osteoclast activity (as
summarized in Figure 1). Recently, Gram-negative bacterial LPS
has been demonstrated to induce osteoclastogenesis and reduce
bone volume following in vivo administration, and this effect
was blocked by co-administration of OPG (Ochi et al., 2010).
While most cultured mononuclear osteoclasts die within 24 h in
the absence of stimuli, both RANKL and bacterial LPS support
survival and induce differentiation into multinuclear cells, pro-
viding a potential mechanism underlying LPS-induced bone loss
(Suda et al., 2002). Such an effect does not appear to be lim-
ited to Gram-negative bacterial products, as S. aureus binding to
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osteoblasts can induce the release of soluble RANKL by these cells
(Widaa et al., 2012). Furthermore, biofilm components from a
clinical S. aureus strain have recently been demonstrated to induce
osteoblast RANKL production and increase the RANKL/OPG
ratio in culture media (Sanchez et al., 2013). In particular, staphy-
lococcus protein A (SpA) has been reported to bind to TNF
receptor 1 (TNFR1) on osteoblasts (Claro et al., 2013), and
S. aureus-induced increases in osteoblast RANKL expression are
not seen with SpA mutants (Claro et al., 2011). However, one
study suggests that S. aureus surface-associated material can pro-
mote osteoclast formation in vitro in a RANKL independent
manner (Lau et al., 2006), while another indicates that LPS-
induced bone resorption can occur independent of RANKL or the
inflammatory mediators IL-1β or TNF-α (Suda et al., 2002). As
such, it is possible that bacterial products can have both direct and
indirect effects on osteoclast activity in inflammatory bone loss.
It is important to note that some bacterial pathogens appear
to manipulate bone homeostasis in a species-specific manner.
For example, P. gingivalis culture products including hemoglobin
receptor protein can suppress RANKL-induced in vitro osteoclas-
togenesis (Fujimura et al., 2006). It seems likely that differences in
the manipulation of bone tissue reflect distinct bacterial survival
and/or dissemination strategies. While net resorption of bone
may favor S. aureus and Salmonella infections, rapid and exten-
sive destruction of alveolar bone would be anticipated to result
in tooth loss and the elimination of the gingival crevice that is an
anatomical niche for periodontal pathogens such as P. gingivalis.
A suppressive effect of this organism on osteoclastogenesis may,
therefore, permit chronic infection (Fujimura et al., 2006).
INDUCTION OF APOPTOSIS IN BONE FORMING
OSTEOBLASTS DURING OSTEOMYELITIS
In addition to the increased formation and activity of bone
resorbing osteoclasts in osteomyelitis, inflammatory bone loss
may also result from the elimination of the cells responsible for
new bone matrix deposition following infection. In support of
this notion, reduced expression of markers associated with dif-
ferentiated osteoblasts including alkaline phosphatase activity,
collagen type I production, and mineralized nodules, is seen in
alveolar bone tissue from patients with periodontal disease (Mori
et al., 2007). Importantly, work from our laboratory and our
collaborators have demonstrated that bone-forming osteoblasts
undergo apoptotic cell death following infection with the prin-
ciple causative agents of osteomyelitis, S. aureus and Salmonella
(Tucker et al., 2000; Alexander et al., 2003). We have shown
that Salmonella enterica can elicit significant apoptotic cell death
as rapidly at 24 h post-infection. Interestingly, we have found
that intracellular invasion is required for maximal induction of
apoptosis in osteoblasts as evidenced by the sensitivity of this
response to a pharmacological inhibitor of endocytosis and a sig-
nificantly smaller apoptotic response in this cell type to invasion
deficient Salmonella strains (Marriott et al., 2005; McCall et al.,
2008). As such, inflammatory bone loss during osteomyelitis may
result from the elimination of the cells responsible for new bone
matrix deposition in addition to the increased numbers and activ-
ity of bone resorbing osteoclasts at sites of bacterial infection
(Nair et al., 1996). Along these lines, it is becoming apparent
that the causative agents of osteomyelitis are capable of induc-
ing continuous apoptosis of bone lining osteoblasts by activating
intrinsic and extrinsic cell death pathways to further uncouple
bone formation and resorption.
DIRECT INDUCTION OF OSTEOBLAST CELL DEATH
FOLLOWING BACTERIAL CHALLENGE
Clinical S. aureus strain biofilm components have been shown
to inhibit osteoblast differentiation and reduce viability with
increased rates of apoptosis (Sanchez et al., 2013). Similarly,
S. aureus binding to osteoblasts inhibits de novo bone formation
by preventing expression of key products including alkaline phos-
phatase, collagen type I, osteocalcin, and osteopontin (Widaa
et al., 2012). SpA appears to underlie this effect as this product
can directly bind osteoblasts, inhibit proliferation and miner-
alization, and initiate apoptosis in this cell type (Claro et al.,
2011). A role for SpA binding to osteoblasts in inducing apop-
tosis is supported by the observation that these effects are not
seen with SpA deficient bacterial mutants (Claro et al., 2011;
Widaa et al., 2012). Similarly, A. actinomycetemcomitans extracts
can also induce the death of osteoblast-like cells (Morimoto et al.,
1999). Again, a bacterial protein product appears to underlie
this phenomenon as cycloheximide-treated A. actinomycetem-
comitans fails to induce osteoblast death, and heat or trypsin
treatment of bacterial extracts neutralizes this effect (Morimoto
et al., 1999). Although, it should be noted that at least one
study suggests that A. actinomycetemcomitans-induced osteoblast
apoptosis can be mediated by a capsular-like polysaccharide
(Yamamoto et al., 1999). Interestingly, while P. gingivalis lipids
can inhibit osteoblast differentiation and activity, they do not sig-
nificantly alter osteoblast viability (Wang et al., 2010), but binding
between the fimbriae of this organism and the host cell integrin
alpha5beta1 can initiate apoptosis in this cell type (Zhang et al.,
2013). However, such induction appears to be a delayed effect as
P. gingivalis prolongs cell life prior to host cell destruction (Zhang
et al., 2013), presumably to permit bacterial replication within the
osteoblast.
We have demonstrated that osteoblasts express members of
the TLR family of pattern recognition receptors and that these
cell surface sensors can detect the presence of extracellular bacte-
ria and their products (Kikuchi et al., 2001; Gasper et al., 2002;
Madrazo et al., 2003). However, our studies indicate that bacte-
rial components, UV-inactivated bacteria and invasion defective
strains of bacteria are far less effective in eliciting the osteoblast
immune functions than viable wild type bacteria (Bost et al.,
1999, 2000, 2001). Furthermore, Thammasitboon et al. (2006)
have demonstrated that bacterial components such as LPS fail to
elicit apoptosis in osteoblasts. Consistent with these findings, we
have shown that cytochalasin significantly attenuates inflamma-
tory cytokine production by invasive Salmonella (McCall et al.,
2008). These observations indicate that invasion is required for
optimal osteoblast responses and suggest that the cell surface
TLRs are not the only means by which these cells perceive bac-
terial pathogens. This phenomenon might be explained by our
finding that osteoblasts express NOD1 andNOD2 (Marriott et al.,
2005), two members of the NLR family of receptor proteins that
can serve as intracellular sensors for bacterial peptidoglycans and
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initiate pro-inflammatory mediator production (as reviewed in
Ting and Davis, 2005; Strober et al., 2006).
The importance of bacterial invasion in the initiation of
osteoblast apoptosis is underscored by the demonstration that
the presence of intracellular S. aureus causes rounding of this
cell type and chromatin condensation, DNA laddering, and DNA
strand breaks in the nuclei (Tucker et al., 2000). Furthermore,
S. aureus-induced apoptosis in human osteoblasts is markedly
attenuated following inhibition of cellular invasion (Ning et al.,
2011). Similarly, the Gram-negative bacteria P. gingivalis and
B. abortus, causative agents of periodontitis and osteomyelitis,
respectively, are capable of invading osteoblasts, although these
organisms appear to elicit delayed apoptosis thereby permitting
intracellular replication (Wang et al., 2010; Scian et al., 2012; Baldi
and Giambartolomei, 2013; Zhang et al., 2013). Finally, similar
to inflammatory mediator production, our studies indicate that
invasive bacteria are more effective at inducing osteoblast apop-
tosis with S. aureus or S. typhimurium SB300 being significantly
more potent stimuli for murine osteoblast cell death than the
invasion defective species, S. carnosus and S. typhimurium SB136
(Marriott et al., 2005).
While NOD1 and NOD2 can initiate, augment, or reduce
inflammatory mediator production by a variety of cell types
(as reviewed in Inohara and Nunez, 2003), these cytosolic pro-
teins are not widely recognized to participate in the induction of
apoptosis. In contrast, two related receptors, NLR family CARD
domain containing 4 (NLRC4) and NLR family pyrin domain
containing 3 (NLRP3), have been implicated in the induction
of cell death in response to bacteria and/or their components
(Gumucio et al., 2002; Mariathasan et al., 2004, 2006; Sutterwala
et al., 2006). Both of these molecules can associate with an
adaptor protein, apoptosis-associated speck-like protein (ASC) to
elicit caspase-1 and caspase-8 activation (Hasegawa et al., 2005;
Mariathasan, 2007), enzymes that demonstrate elevated activity
in osteoblasts following bacterial challenge (Marriott et al., 2002;
Alexander et al., 2003). We have recently investigated the func-
tional expression of NLRP3 and NLRC4 in resting and Salmonella
exposed cultures of primary murine and human osteoblasts in
an attempt to identify the mechanisms linking intracellular inva-
sion to bacterially-induced cell death. We demonstrated that
osteoblasts constitutively express NLRP3, but not NLRC4, and
such expression was modestly increased following infection with
wild type S. enterica (McCall et al., 2008). This finding was in
contrast with the significant decrease in NLRP3 protein levels
seen in osteoblasts following exposure to an invasion defective
strain. In addition to showing that osteoblasts possess robust con-
stitutive levels of NLRP3, we demonstrated that these cells also
express ASC. While constitutive levels of ASC were low in resting
osteoblasts, a marked elevation in expression was observed in cells
following Salmonella infection (McCall et al., 2008).
Taken together, the conserved expression of NLRP3 and ASC
in both mouse and human osteoblasts, and the sensitivity of such
expression to bacterial challenge, provides circumstantial evi-
dence of a role for these cytosolic proteins in osteoblast responses
to intracellular pathogens. However, we have more directly ver-
ified NLRP3 functionality in bacterially challenged osteoblasts
(McCall et al., 2008). First, we have shown that NLRP3 associates
with ASC following exposure to Salmonella as determined by
co-immunoprecipitation. Second, we have demonstrated that
NLRP3 expression knockdown by siRNA attenuates Salmonella-
induced changes in transcription factor activity. Third, we have
found that osteoblasts derived fromNLRP3 deficient animals pro-
duce less IL-6 than cells derived from wild type mice. As such,
these findings confirm that NLRP3 mediates, at least in part,
osteoblast responses to this intracellular bacterial pathogen.
Given that osteoblasts constitutively express NLRP3 and ASC,
and the finding that NLRP3 can associate with ASC to elicit
caspase-1 (Gumucio et al., 2002; Dowds et al., 2004; Kanneganti
et al., 2006; Mariathasan et al., 2006) and perhaps caspase-
8 activation (Hasegawa et al., 2005), enzymes that demon-
strate elevated activity in osteoblasts following bacterial challenge
(Marriott et al., 2002; Alexander et al., 2003), this cytosolic NLR
may represent an important mechanism underlying osteoblast
apoptosis following exposure to intracellular bacterial pathogens.
This hypothesis is supported by our observation that Salmonella-
induced decreases in NF-kB activity are markedly attenuated
in osteoblasts following siRNA-induced NLRP3 knockdown
(McCall et al., 2008), since this transcription factor has been
reported to mediate anti-apoptotic effects in a variety of cell
types (You et al., 2001; Lu et al., 2004; Munshi et al., 2004).
Furthermore, we have shown that Salmonella-induced caspase-1
activation is absent in osteoblasts derived from NLRP3 deficient
animals (McCall et al., 2008). More importantly, we have demon-
strated that such cells exhibit significantly less apoptotic cell death
following Salmonella infection than osteoblasts derived from wild
type animals (McCall et al., 2008). These findings differ from
studies in macrophages (Mariathasan et al., 2004, 2006) where
NLRP3 is not required for Salmonella-induced caspase-1 acti-
vation, IL-1β production, or cell death. Instead, these functions
are predominantly mediated by NLRC4 (Mariathasan et al., 2004,
2006). In osteoblasts, NLRP3 is required for caspase-1 activation
and for a portion of Salmonella-induced cell death, while NLRC4
is not detectable in these cells. Furthermore, earlier work from our
laboratory has indicated that neither the precursor nor themature
form of IL-1β is produced by infected osteoblasts (Marriott et al.,
2002). Together these studies underscore the differences between
osteoblasts and macrophages and show that at least one of these
is a differential reliance on NLRP3 vs. NLRC4 in cell death fol-
lowing Salmonella infection. This illustrates an additional level
of complexity in the control of cellular functions by NLR family
members.
While further experimentation is required to definitively con-
clude that ASC and alterations in NF-kB activity are essential
mechanistic elements inNLRP3-mediated apoptosis in bacterially
challenged osteoblasts, these studies indicate that this NLR repre-
sents an important component underlying the direct initiation of
apoptosis in this bone-forming cell type following challenge with
intracellular bacterial pathogens and could, therefore, be a major
contributory factor to bone loss at sites of infection.
INDIRECT INDUCTION OF OSTEOBLAST CELL DEATH VIA
LEUKOCYTE/BONE CELL DERIVED MEDIATORS
The extrinsic pathway of programmed cell death begins with lig-
ation of a particular group of cell surface receptors and leads to
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recruitment of adaptor molecules and the activation of a caspase
cascade that results in cellular disassembly. This apoptotic pathway
is critically regulated by members of the TNF family of cytokines
and receptors in many cell types (Cosman, 1994; Lynch et al.,
1994; Smith et al., 1994). Ligands such as TNF-α and Fas ligand
have the ability to interact with death domain containing receptors
to initiate apoptosis and conditioned medium from LPS-treated
macrophage-like cells has been shown to induce osteoblast apop-
tosis in aTNF-αdependentmanner (Thammasitboon et al., 2006).
Similarly, the supernatants from B. abortus-infected macrophages
can induce osteoblast apoptosis in a TNF-α-dependent manner
(Scian et al., 2012), which could therefore contribute to the bone
and joint destruction seen in patients with osteoarticular com-
plications of brucellosis. However, it is important to note that
the events that occur in vivo are likely to be more complex as
illustrated by the observation that LPS-induced TNF-α produc-
tion only provokes in situ osteoblast apoptosis when the TNFR1
signal is negated, suggesting that this receptor can also regulate
osteoblast survival (Ochi et al., 2010).
TNF-related apoptosis inducing ligand (TRAIL) is also amem-
ber of the TNF superfamily and this soluble protein has the
unique ability to interact with five different receptors. TRAIL can
interact with death receptor (DR)4 (also known as TRAIL R1)
(Pan et al., 1997), DR5 (also known as TRAIL R2 and TRAIL
receptor inducer of cell killing-2) (Schneider et al., 1997), DcR1
(also known as TRAIL R3 and TRAIL receptor without an intra-
cellular domain) (Degli-Esposti et al., 1997), DcR2 (also known as
TRAIL R4 and TRAIL receptor with a truncated death-domain)
(Pan et al., 1998), and finally soluble OPG (Emery et al., 1998).
Of these receptors, only DR4 and DR5 in humans and DR5 in
mice have functional cytoplasmic death-domains and are capable
of inducing apoptosis, while DcR1 and DcR2 appear to function
as decoy receptors (Clancy et al., 2005). Death domain-containing
receptors trimerize to allow TRAIL to bind and trigger caspase 8
activation that directly activates caspases 3 and 7 via the extrinsic
pathway (Clancy et al., 2005). Although it should be noted that
that TRAIL has been also been suggested to activate the intrinsic
pathway through the activation of BH3 interaction-domain death
agonist (Bid) (Suliman et al., 2001; Sinicrope and Penington,
2005). Both of these pathways lead to caspase 3 activation and cell
death (Suliman et al., 2001). In contrast, OPG appears to function
as a soluble decoy receptor for both TRAIL and the potent osteo-
clastogenic factor, RANKL. As such, excessive TRAIL secretion in
bone tissue would be anticipated to decrease the amount of OPG
available to bind RANKL, leading to increased osteoclastogenesis
and tissue loss (as illustrated in Figure 1).
In a recent study (Young et al., 2011), we have demonstrated
that murine osteoblasts constitutively express mRNA encoding
the sole murine death-domain containing TRAIL receptor, DR5,
and we have shown that resting cultures of these cells contain
robust levels of the DR5 protein. These observations are consis-
tent with previous reports that human osteoblast-like cells express
mRNA encoding DR4 and DR5 (Atkins et al., 2002). However,
we have shown that DR5 expression on the surface of murine
osteoblasts is restricted to cells exposed to either S. aureus or
Salmonella (Young et al., 2011). Similarly, we confirmed that both
of the death-domain containing TRAIL receptors on human cells
are only present on primary human osteoblasts following bacte-
rial challenge and the conserved nature of this response supports
the biological significance of such expression on infected cells
(Young et al., 2011). In the same work, we showed that the robust
constitutive production of the decoy TRAIL receptor OPG by
resting osteoblasts was markedly attenuated following infection
with either S. aureus or Salmonella (Young et al., 2011). While
other studies indicate that serum OPG levels increase following
systemic bacterial LPS administration (Maruyama et al., 2006),
our results are consistent with reports that the causative agents
of periodontitis and LPS can similarly decrease OPG expression
by murine osteoblasts (Chung et al., 2006; Mori et al., 2007).
Furthermore, it should be noted that bone tissue is relatively
poorly vascularized and bone infections are more commonly
associated with Gram-positive bacterial species such as S. aureus,
infections that do not result in the development of endotoxic
shock. As such, changes in OPG expression by resident bone cells
are likely to be more physiologically relevant in local bone infec-
tions than the systemic effects elicited by bacterial endotoxins.
As such, these data suggest that the principle causative agents of
osteomyelitis can elicit an imbalance in the expression of death-
inducing and decoy TRAIL receptors by osteoblasts, with the
induced expression of DR5 and/or DR4 on the surface of infected
cells and a concomitant decrease in the production of the decoy
receptor, OPG.
Osteoblasts isolated from alveolar bone of patients with peri-
odontal disease have been demonstrated to have higher sen-
sitivity to the apoptosis-inducing actions of TRAIL than cells
isolated from healthy donors (Mori et al., 2009). In our recent
work, we tested the sensitivity of primary osteoblasts to exoge-
nously administered recombinant TRAIL at rest or following
challenge with either S. aureus or Salmonella (Young et al., 2011).
Consistent with the absence of death-inducing TRAIL receptors
on uninfected osteoblasts and previous reports with unstimu-
lated human osteoblast-like cells (Atkins et al., 2002; Bu et al.,
2003), we showed that TRAIL fails to activate apoptosis signal-
ing pathways in uninfected primary osteoblasts (Young et al.,
2011). However, acute bacterial exposure sensitizes osteoblasts to
TRAIL-mediated cell death as shown by the ability of exogenous
TRAIL to augment apoptotic volume decreases and caspase-8
activation following S. aureus or Salmonella infection (Alexander
et al., 2003; Young et al., 2011). While increased TRAIL-induced
apoptosis is only correlative with the observed induction of
cell surface death receptor expression, we have previously doc-
umented that TRAIL neutralizing antibodies can significantly
inhibit bacterially-induced osteoblast apoptosis as assessed by
caspase-8 activation and annexin V staining (Alexander et al.,
2003). Together, these results support the contention that the
induced expression of death receptors renders these cells sensi-
tive to the apoptotic actions of TRAIL, and provide a potential
mechanism underlying the reported increase in TRAIL sensitivity
of human alveolar osteoblasts isolated from patients with peri-
odontitis (Mori et al., 2009) and transformed osteoblasts (Atkins
et al., 2002).
Several studies have shown that human osteoblast-like cells
express TRAIL (Atkins et al., 2002; Bu et al., 2003) and work
from our laboratory has demonstrated that exposure of mouse
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and human primary osteoblasts to S. aureus or Salmonella
induces TRAIL expression by these cells (Alexander et al.,
2001). Furthermore, we have also shown that bacterial infection
enhances RANKL expression and release by osteoblasts (Somayaji
et al., 2008). Since RANKL binds OPG with a similar bind-
ing affinity to that of TRAIL (23 and 45 nM for RANKL and
TRAIL, respectively (Vitovski et al., 2007), this molecule could
further reduce levels of OPG available to bind and neutralize
TRAIL. Accordingly, a scenario could be envisaged in which bac-
terially challenged osteoblasts express TRAIL and RANKL while
concomitantly decreasing the production of the decoy receptor
OPG and upregulating cell surface death receptor expression. The
increased production of this death receptor ligand, in concert
with reduced OPG production and bioavailability, would facili-
tate TRAIL activity and result in the death of infected osteoblasts,
providing an additional mechanism whereby bacterial pathogens
elicit bone destruction during diseases such as osteomyelitis (as
shown in Figure 1).
CONCLUDING REMARKS
The inflammatory bone loss associated with osteomyelitis can
result from the direct destruction of bone tissue by bacteria and
their products. Furthermore, significant bone loss is likely to
result from the recruitment and activation of infiltrating leuko-
cytes such as neutrophils and macrophages. The direct activa-
tion of these cells by bacteria via an array of cell surface and
cytosolic pattern recognition receptors, and the presence of an
inflammatory milieu at the site of infection, results in the produc-
tion of degradative enzymes and cytotoxic molecules. Consistent
with host-pathogen interactions at other anatomical sites, the
microbes responsible for bone infections can manipulate leuko-
cyte survival pathways in a bacterium specific manner with
some organisms inducing apoptosis and/or pyroptotic cell death,
while other organisms appear to promote the survival of innate
immune cells, particularly neutrophils. While lengthening the life
span of these cells might represent an attempt by the host to clear
the infection, the unintended consequence of such a vigorous
response can be extensive inflammatory bone destruction.
However, bone loss at sites of infection is primarily due to
an uncoupling of the control of bone forming osteoblasts and
bone resorbing osteoclasts. Bacteria or their products can directly
increase the osteoclast formation and activity. In addition, inflam-
matory mediators produced at the site by infiltrating leukocytes
or bacterially challenged osteoclasts themselves can further pro-
mote osteoclastogenesis and bone resorption. Importantly, the
production and activity of osteoclasts is critically regulated by
osteoblasts, and these cells have recently been found to respond to
the principle causative agents of osteomyelitis via TLR and NLR
family members. Osteoblasts exposed to bacteria express an array
of soluble and cell surface molecules that have the potential to
promote immune responses and directly or indirectly enhance
osteoclast activity at sites of infection.
In addition to the increased number and activity of bone
resorbing osteoclasts, it is becoming apparent that bone loss
during conditions such as osteomyelitis is also brought about
by a decline in new bone deposition. This occurs as a result
of decreased production of matrix components by osteoblasts
and by increased rates of apoptosis in this cell type. While the
presence of certain extracellular bacterial components may be
sufficient to directly reduce osteoblast viability, there is consid-
erable evidence that internalization of the principal causative
agents of osteomyelitis is required to maximally induce apop-
tosis in these cells. At least a component of such cell death is
attributable to osteoblast-derived TRAIL acting in an autocrine
and/or paracrine manner via death domain-containing receptors
that are concomitantly and exclusively expressed by infected cells.
However, TRAIL-induced death is unlikely to be the sole means
by which osteoblasts are eliminated in infected tissue. Indeed,
rapid activation of apoptotic pathways is observed in microbe
challenged osteoblasts prior to TRAIL production, and at least a
proportion of this cell death is unaffected by anti-TRAIL anti-
bodies (Alexander et al., 2001, 2003). Such cell death may result
from the direct activation of cytosolic NLRP3 that is constitu-
tively expressed by osteoblasts (McCall et al., 2008), which can
activate caspase cascades and initiate apoptosis. As such, NLRP3
may act in concert with TRAIL-mediated pathways to eliminate
osteoblasts in infected bone tissue.
It might be anticipated that new therapies that target the per-
ception and initiation of inflammatory immune responses and
bone-forming cell death via pattern recognition receptors would
be of considerable benefit in reducing the inflammatory dam-
age and cell death associated with bone infections. However, it
is important to note that many of these observations have been
made in reductive in vitro systems and have yet to be confirmed
in vivo. Also, it is clear that important issues regarding bacteria-
induced inflammatory bone loss remain unresolved. For example,
it is not known whether osteocytes embedded within calcified
bone can respond to bacteria, an important question given the
critical role of cell type in controlling bone surface cells via
the lacuna-canaliculi network (Matsuo, 2009). Furthermore, the
mechanism that is the most important in the pathophysiology
of bacterium-induced bone loss has not been identified, and this
issue is further complicated by the disparate nature of the bac-
terial species that are responsible for bone diseases. As such, it
is not presently known whether inhibition of osteoclast forma-
tion/activity or the prevention of osteoblast destruction would
be most efficient in eliminating bacterially-induced bone loss.
Finally, given that infected osteoblasts may harbor intracellular
bacteria such as S. aureus and promote inflammatory bone dam-
age, it is not clear whether the host would be best served by
preventing osteoblast cell death or by eliminating these cells via
the induction of apoptosis. Clearly, further work is warranted to
resolve these issues.
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